NCT02715609View on ClinicalTrials.gov

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2016

Primary Completion Date

May 12, 2024

Study Completion Date

May 12, 2024

Conditions

Glioblastoma Multiforme

Interventions

DRUG

Disulfiram

DRUG

Copper Gluconate

PROCEDURE

Surgery

RADIATION

Radiation

DRUG

Temozolomide

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT02715609 - Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma | Biotech Hunter | Biotech Hunter